posted on 2022-09-15, 15:47authored byAndreas Greinacher, Florian Langer, Linda Schonborn, Thomas Thiele, Munif Haddad, Thomas Renne, Jerome Rollin, Yves Gruel, Theodore E Warkentin
Transient prothrombotic disorders caused by plateletactivating antibodies against platelet factor 4 (PF4) include heparin-induced thrombocytopenia (HIT), spontaneous HIT syndrome,1 and, most recently, vaccine-induced immune thrombotic thrombocytopenia (VITT).2 Here, we identified prothrombotic, platelet-activating anti-PF4 antibodies, not associated with heparin treatment, in a patient with monoclonal gammopathy that resulted in a chronic hypercoagulability state.
Funding
Deutsche Forschungsgemeinschaft, grant/award numbers: 374031971-TRR 240 and KFO306.
History
Comments
The original article is available at https://haematologica.org/
Published Citation
Greinacher A, et al. Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy. Haematologica. 2022;107(5):1219-1221.